Artículos del autor

solaci

Institutional News

Venezuela Sessions 2021

We invite you to revisit the XLII SOLACI Venezuela Sessions (14th Andean Region), and the XVIII SOVECI...
solaci -
Events

37th Annual Meeting of the Uruguayan Society of Cardiology: Registration Waiver for SOLACI Members!

The 37° Annual Meeting of the Uruguayan Society of Cardiology, to be held virtually from May 26...
solaci -
Antiplatelet

ACC 2021 | HOST-EXAM: Clopidogrel vs ASA monotherapy post DAPT in PCI patients

Clopidogrel monotherapy after dual antiplatelet therapy (DAPT) was associated with reduced mortality, MI, stroke, and other events...
solaci -
Institutional News

Watch again our Webinar on Update on the Treatment of Acute Coronary Syndromes without ST Segment Elevation

Watch again our Webinar on "Update on the Treatment of Acute Coronary Syndromes without ST Segment Elevation"...
solaci -
Structural heart disease

ACC 2021 | ATLANTIS 4D-CT: Apixaban and Sub-Clinical Thrombosis After TAVR

Indicating apixaban after transcatheter aortic valve replacement (TAVR) does not significantly reduce the risk of sub-clinical leaflet...
solaci -
Coronary Disease

ACC 2021 | RAPID-TnT: Usefulness of High-Sensitivity Ultra-Fast Troponin T

Patients under evaluation for acute coronary syndrome (ACS) without clear ischemia signs in an electrocardiogram find no...
solaci -
Femoropopliteal

ACC 2021 | SAFE-PAD: Paclitaxel-Eluting Devices in Peripheral Disease

This work was conducted alongside the US Food and Drug Administration (FDA) to investigate the association between...
solaci -
Antithrombotic Anticoagulants

ACC 2021 | ATLANTIS: Apixaban After TAVR vs. Standard of Care

Adding apixaban to the treatment of patients undergoing transcatheter aortic valve replacement (TAVR) was non-superior to standard...
solaci -